Zydus Lifesciences informs about press release

30 Apr 2025 Evaluate
 Zydus Lifesciences has informed that it enclosed a copy of press release dated April 30, 2025, titled ‘Zydus receives final approval from USFDA for Niacin Extended-Release Tablets USP, 500 mg, 750 mg, and 1,000 mg’. 

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

901.60 -2.40 (-0.27%)
30-Dec-2025 11:48 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1713.20
Dr. Reddys Lab 1268.00
Cipla 1489.90
Zydus Lifesciences 901.60
Lupin 2073.10
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×